Read full article.

Drug Matched To Cancer Patients According To Tumour Gene Testing Shows Signs Of Being Effective In Early Trial

(ECCO) Nov 13, 2018 - Treatment with capivasertib, a drug designed to work against a particular gene mutation found in some tumours, shows signs of being effective in a trial of 35 patients presented today (Tuesday) at the 30th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Dublin, Ireland. The phase 2 trial (EAY131-Y) is part of a larger USA study, called NCI-MATCH (EAY131) [2], that aims to determine whether cancer patients can be treated successfully by selecting therapies that target gene abnormalities found in their tumours, rather than by cancer type.
Read full article.

Side Effects From Certain Immunotherapies May Be Higher Than Initially Reported

Read full article.